Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.8 USD | -1.57% | -3.06% | +29.32% |
Financials (USD)
Sales 2024 * | 42.58M | Sales 2025 * | 114M | Capitalization | 1.64B |
---|---|---|---|---|---|
Net income 2024 * | -318M | Net income 2025 * | -361M | EV / Sales 2024 * | 37 x |
Net cash position 2024 * | 68.82M | Net Debt 2025 * | 36.47M | EV / Sales 2025 * | 14.8 x |
P/E ratio 2024 * |
-5.35
x | P/E ratio 2025 * |
-4.97
x | Employees | 385 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.35% |
Latest transcript on Agios Pharmaceuticals, Inc.
1 day | -0.85% | ||
1 week | +5.63% | ||
Current month | +0.07% | ||
1 month | -2.27% | ||
3 months | +28.67% | ||
6 months | +26.56% | ||
Current year | +31.39% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Goff
CEO | Chief Executive Officer | 55 | 22-08-07 |
Cecilia Jones
DFI | Director of Finance/CFO | 49 | 22-09-25 |
Jacqualyn Fouse
CHM | Chairman | 62 | 17-12-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Capello
BRD | Director/Board Member | 69 | 23-05-31 |
Director/Board Member | 64 | 14-12-08 | |
May Kin Ho
BRD | Director/Board Member | 71 | 15-06-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.52% | 1 M€ | -1.52% | - | |
0.16% | 0 M€ | 0.00% | - | |
0.14% | 0 M€ | 0.00% | - | |
0.06% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-15 | 29.26 | -0.85% | 617,987 |
24-04-12 | 29.51 | -3.66% | 754,242 |
24-04-11 | 30.63 | +2.30% | 802,781 |
24-04-10 | 29.94 | +0.77% | 738,822 |
24-04-09 | 29.71 | +7.26% | 959,037 |
Delayed Quote Nasdaq, April 15, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.39% | 1.64B | |
-2.34% | 103B | |
+2.31% | 96.56B | |
-0.55% | 22.61B | |
-16.72% | 21.18B | |
-4.36% | 19.07B | |
-41.75% | 16.53B | |
-23.26% | 14.46B | |
-0.02% | 13.25B | |
+22.69% | 11.1B |
- Stock Market
- Equities
- AGIO Stock